|
|
GlaxoSmithkline Healthcare net up 4.3 pc in Q2
|
|
|
|
| Top Stories |
 |
|
|
|
SME Times News Bureau | 08 Nov, 2017
GlaxoSmithkline Consumer Healthcare Ltd on Tuesday reported a Rs
192-crore net profit for the second quarter (Q2) of fiscal 2017-18,
registering a marginal 4.3 per cent annual growth from Rs 184 crore in
the same period last year.
Sequentially, however, the net profit for Q2 is 46 per cent up from Rs 132 crore posted in the last quarter.
In
a regulatory filing on the BSE, the NCR-based company said the revenue
from operations at Rs 1,115 crore for Q2 was 6.5 per cent annually lower
than Rs 1,193 crore in the like period of last year but up 6.6 per cent
sequentially from Rs 1,046 crore in the last quarter.
The blue
chip company's scrip of Rs 10 face value lost Rs 43 per share in
Tuesday's trading on the BSE to end at Rs 5,466.05 from Monday's closing
rate of Rs 5,509.65 and opening price of Rs 5,549.95.
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Customs Exchange Rates |
| Currency |
Import |
Export |
US Dollar
|
84.35
|
82.60 |
UK Pound
|
106.35
|
102.90 |
Euro
|
92.50
|
89.35 |
| Japanese
Yen |
55.05 |
53.40 |
| As on 12 Oct, 2024 |
|
|
| Daily Poll |
 |
 |
| Do you think Indian businesses will be negatively affected by Trump's America First Policy? |
|
|
|
|
|
| Commented Stories |
|
|
|
|
|
|
| |
|
